Hydroxyurea, blood transfusions, and donor blood stem cell transplants can significantly lower the risk of stroke in children and adolescents…
Articles by Patricia Inácio, PhD
Oryzon Genomics said it received European Medicines Agency approval to start a Phase 1b clinical trial of iadademstat in…
The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to Beam Therapeutic’s BEAM-101,…
Women with sickle cell disease (SCD) experience nearly double the rate of acute pain associated with the disease in…
Zynext Ventures is investing in Illexcor Therapeutics to advance the clinical development of ILX002, its lead, novel oral…
Despite advancements in medical care, pregnant women with sickle cell disease (SCD) are at a higher risk of complications…
The incidence of vaso-occlusive episodes and acute chest syndrome in children with sickle cell disease (SCD) is elevated during…
Texas Children’s Global HOPE and Baylor College of Medicine Global Health, collaborating with the independent charity Bristol Myers Squibb Foundation,…
Mitem Pharma has acquired worldwide rights to Desferal (deferoxamine), a therapy commonly used to lower excessive and damaging…
The NewYork-Presbyterian Dalio Center for Health Justice is using basketball to raise awareness about sickle cell disease (SCD). The…